Latest Balance Sheet News

BOA Resources Ltd reported a significant cash flow decline in Q4 2025, with cash reserves dropping sharply. The company plans a capital raise to bolster its financial position and support upcoming exploration activities.

Cluey Ltd reports a 13% improvement in operating cash outflow and a 0.7% rise in gross profit margin, while preparing to launch its AI-driven Cluey+ platform in February 2026. The company also completed a $4.5 million capital raise and signed an agreement to acquire the Art of Smart group.

Felix Group Holdings reported a robust 47% increase in total annual recurring revenue for Q2 FY26, driven by the strategic acquisition of Nexvia and expanding enterprise contracts. The company is advancing AI-powered platform enhancements and navigating key leadership transitions.

Pilot Energy has made significant strides in Q4 2025 with the launch of a modular data centre joint venture, progress on a hybrid solar and battery project, and advancement of offshore gas exploration partnerships, supported by substantial new financing.

Golden Horse Minerals reports multiple shallow, high-grade gold intersections at Golden Valley and significant deep drilling success at Southern Cross, backed by a $35 million capital raise to fuel 2026 growth.

Holista Colltech has reported a positive operating cash flow for the December quarter, driven by disciplined cost management and a successful capital raise, despite softer sales and ongoing legal disputes.

Nagambie Resources and Alkane Resources have entered a binding agreement for a joint venture that could see Alkane invest up to $27.5 million to earn an 80% stake in Nagambie's key mining tenements, leveraging Alkane’s existing processing infrastructure to accelerate production.

FlexiRoam has reported its second consecutive quarter of positive operating cash flow and returned to a positive net current asset position for the first time in over eight years, underpinned by record underlying EBITDA and strategic AI partnerships.

Janus Electric reports operational progress with validated technology and increased revenue, while focusing on commercial execution and cost discipline under new CEO Ben Hutt. Funding remains a critical factor for sustaining growth.

Entropy Neurodynamics has successfully enrolled and dosed the first patient in its pioneering clinical trial of TRP-8803, an intravenous psilocin formulation targeting Binge Eating Disorder, while securing $6.1 million in new funding to accelerate development.

Neurotech International has secured a Rare Pediatric Disease Designation from the FDA for its lead drug NTI164 targeting Rett syndrome, alongside publishing promising clinical data and raising $8.7 million to fuel further development.

Solis Minerals has made a decisive leap in its Peruvian copper-gold exploration with the acquisition of the Cucho Project and a successful $5.9 million capital raise, setting the stage for an active 2026 drilling campaign.